High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Clinical Oncology

• Publication date

  2008-01-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2007.12.8298PMID 18086798
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The CCL3 Family of Chemokines and Innate Immunity Cooperate In Vivo in the Eradication of an Established Lymphoma Xenograft by Rituximab1

  2007cited by this paper
• Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.

  2007cited by this paper
• The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma.

  2006cited by this paper
• Follicular lymphoma international prognostic index

  2006cited by this paper
• Prognostic significance of PU.1 in follicular lymphoma

  2006cited by this paper
• Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion.

  2006cited by this paper
• Immunohistochemical analysis of the antiapoptotic Mcl‐1 and Bcl‐2 proteins in follicular lymphoma

  2006cited by this paper
• Ex Vivo-activated Human Macrophages Kill Chronic Lymphocytic Leukemia Cells in the Presence of Rituximab: Mechanism of Antibody-dependent Cellular Cytotoxicity and Impact of Human Serum

  2006cited by this paper
• Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients.

  2006cited by this paper
• Update of the FL2000 randomized trial combining rituximab to CHVP-Interferon in follicular lymphoma (FL) patients (pts).

  2006cited by this paper
• Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome.

  2006cited by this paper
• High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.

  2006cited by this paper
• Treatment strategies in follicular lymphomas: current status and future perspectives.

  2005cited by this paper
• Increased vascularization predicts favorable outcome in follicular lymphoma.

  2005cited by this paper
• Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL).

  2005cited by this paper
• Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment.

  2005cited by this paper
• Follicular lymphoma international prognostic index.

  2004cited by this paper
• with follicular lymphoma High expression of cyclin B 1 predicts a favorable outcome in patients

  2004cited by this paper
• Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.

  2004cited by this paper
• Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma.

  2004cited by this paper
• Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues

  2003cited by this paper
• Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.

  2002cited by this paper
• Rituximab: Mechanism of action and resistance.

  2002cited by this paper
• Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

  1999cited by this paper

• Biology as vulnerability in follicular lymphoma: genetics, epigenetics, and immunogenetics.

  2025cites this paper
• Molecular mechanisms of TAM-regulated tumorigenesis and progression in various types of radiotherapy and future prospects of radiation-immunotherapy combinations.

  2025cites this paper
• CD27 agonist antibodies mediate clinical responses through intratumoral stimulation in B-cell malignancies: multicenter RiVa trial.

  2025cites this paper
• Molecular Biomarkers in Prediction of High-Grade Transformation and Outcome in Patients with Follicular Lymphoma: A Comprehensive Systemic Review

  2024cites this paper
• Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study

  2024cites this paper
• High Ki-67 Expression Predicting a Risk Factor for the Progression of Disease within 24 Months and Microenvironment in Follicular Lymphoma

  2024cites this paper
• The Oncogenic Lipid Sphingosine-1-Phosphate Impedes the Phagocytosis of Tumor Cells by M1 Macrophages in Diffuse Large B Cell Lymphoma

  2024cites this paper
• Empowering macrophages: the cancer fighters within the tumour microenvironment in mantle cell lymphoma

  2024cites this paper
• Cooperative phagocytosis of solid tumours by macrophages triggers durable anti-tumour responses

  2023cites this paper
• The pathobiology of follicular lymphoma

  2023cites this paper
• Gene expression and copy number profiling of follicular lymphoma biopsies from patients treated with first-line rituximab without chemotherapy

  2023cites this paper
• Integrated single-cell and bulk RNA sequencing in pancreatic cancer identifies disulfidptosis-associated molecular subtypes and prognostic signature

  2023cites this paper
• Follicular lymphoma microenvironment: insights provided by single-cell analysis

  2023cites this paper
• Single-cell profiling identifies clinically relevant interactions between tumor associated macrophages and blood endothelial cells in diffuse large B cell lymphoma

  2022influential citation
• Follicular lymphoma: 2023 update on diagnosis and management

  2022cites this paper
• Unveiling the Role of the Tumor Microenvironment in the Treatment of Follicular Lymphoma

  2022cites this paper
• Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages

  2022cites this paper
• Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV

  2022cites this paper
• Epigenetic, Metabolic, and Immune Crosstalk in Germinal-Center-Derived B-Cell Lymphomas: Unveiling New Vulnerabilities for Rational Combination Therapies

  2022cites this paper
• Tumor Microenvironment and Microvascular Density in Follicular Lymphoma

  2022cites this paper
• Prognostic Value and Correlation With Tumor Immune Infiltration of a Novel Metabolism-Related Gene Signature in Pancreatic Cancer

  2022cites this paper
• Cooperative phagocytosis underlies macrophage immunotherapy of solid tumours and initiates a broad anti-tumour IgG response

  2022cites this paper
• High inter‐follicular spatial co‐localization of CD8+FOXP3+ with CD4+CD8+ cells predicts favorable outcome in follicular lymphoma

  2022cites this paper
• The Role of Metabolic Plasticity of Tumor-Associated Macrophages in Shaping the Tumor Microenvironment Immunity

  2022cites this paper
• Combined tumor‐associated macrophages biomarker predicting extremely poor outcome of patients with primary central nervous system lymphoma

  2021cites this paper
• The Role of Tumor-Associated Macrophages in Hematologic Malignancies

  2021cites this paper
• Tumor microenvironment of follicular lymphoma

  2021cites this paper
• Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma

  2021cites this paper
• RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL OF INTRAVENOUS BELIMUMAB IN PATIENTS

  2021cites this paper
• Immunohistochemical Characterization of Tumor-Associated Macrophages in Canine Lymphomas

  2021cites this paper
• Predicting early progression in follicular lymphoma

  2021cites this paper
• Immune infiltrate diversity confers a good prognosis in follicular lymphoma

  2021cites this paper
• Immuno-oncology for B-cell lymphomas

  2021cites this paper
• Infiltration of CD163‐, PD‐L1‐ and FoxP3‐positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors

  2021cites this paper
• Follicular Lymphoma Microenvironment: An Intricate Network Ready for Therapeutic Intervention

  2021cites this paper
• Follicular lymphoma and macrophages: impact of approved and novel therapies

  2021influential citation
• The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma

  2021cites this paper
• Prognostic Value of Peripheral Blood Lymphocyte/monocyte Ratio in Lymphoma

  2021cites this paper
• The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma.

  2021cites this paper
• Increased tumor-associated macrophages in the prostate cancer microenvironment predicted patients’ survival and responses to androgen deprivation therapies in Indonesian patients cohort

  2020cites this paper
• Impact and Intricacies of Bone Marrow Microenvironment in B-cell Lymphomas: From Biology to Therapy

  2020cites this paper
• HOVON110/ReBeL Study: Results of the Phase I Part of a Randomized Phase I/II Study of Lenalidomide, Rituximab With or Without Bendamustine in Patients With Relapsed/Refractory Follicular Lymphoma

  2020cites this paper
• B-cell non-Hodgkin lymphoma: importance of angiogenesis and antiangiogenic therapy

  2020cites this paper
• Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti-CD20-based Biological Therapy.

  2020cites this paper
• The tumor microenvironment of lymphomas: Insights into the potential role and modes of actions of checkpoint inhibitors

  2020cites this paper
• Role of Microenvironment in Non-Hodgkin Lymphoma

  2020cites this paper
• Precision medicine in follicular lymphoma: Focus on predictive biomarkers

  2020cites this paper
• Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy

  2020influential citation
• Prognostic value of tissue-infiltrating immune cells in tumor microenvironment of follicular lymphoma: A meta-analysis.

  2020cites this paper
• TIGIT Expression Is Associated with T-cell Suppression and Exhaustion and Predicts Clinical Outcome and Anti–PD-1 Response in Follicular Lymphoma

  2020cites this paper
• Anti-CD20 monoclonal antibodies in Systemic Lupus Erythematosus.

  2020cites this paper
• Lymphocyte-to-Monocyte Ratio May Serve as a Better Prognostic Indicator Than Tumor-associated Macrophages in DLBCL Treated With Rituximab

  2019cites this paper
• Targeting the Tumor Microenvironment

  2019cites this paper
• Follicular lymphoma: 2020 update on diagnosis and management

  2019cites this paper
• Recent advances in the first-line treatment of follicular non-Hodgkin lymphoma

  2019cites this paper
• Immune Infiltration and the Potential for a Biology-Guided Approach to Follicular Lymphoma.

  2019cites this paper
• Tumor-Associated Macrophages in Hematologic Malignancies: New Insights and Targeted Therapies

  2019cites this paper
• Lymphomas and Their Microenvironment: A Multifaceted Relationship

  2019cites this paper
• SIRPα expression delineates subsets of intratumoral monocyte/macrophages with different functional and prognostic impact in follicular lymphoma

  2019cites this paper
• Low number of intrafollicular T cells may predict favourable response to rituximab-based immuno-chemotherapy in advanced follicular lymphoma: a secondary analysis of a randomized clinical trial

  2019cites this paper
• Prognostic significance of CD163 expression and its correlation with cyclooxygenase-2 and vascular endothelial growth factor expression in cutaneous melanoma.

  2019cites this paper
• Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy

  2018cites this paper
• Lenalidomide enhances MOR202-dependent macrophage-mediated effector functions via the vitamin D pathway

  2018cites this paper
• Prognostic implications of tumor-infiltrating macrophages, M2 macrophages, regulatory T-cells, and indoleamine 2,3-dioxygenase-positive cells in primary diffuse large B-cell lymphoma of the central nervous system

  2018cites this paper
• A gene-expression profiling score for outcome prediction disease in patients with follicular lymphoma: a retrospective analysis on three international cohorts

  2018cites this paper
• Progress in Tumor‐Associated Macrophages: From Bench to Bedside

  2018cites this paper
• Follicular and Diffuse Large B-Cell Lymphoma - Studies of Primary Treatment and Prognostic Factors

  2018cites this paper
• Current prognostic and predictive factors in follicular lymphoma

  2018cites this paper
• Microenvironment Cell Contribution to Lymphoma Immunity

  2018cites this paper
• MicroRNA signatures and Foxp3+ cell count correlate with relapse occurrence in follicular lymphoma

  2018cites this paper
• Follicular lymphoma: 2018 update on diagnosis and management

  2018cites this paper
• Tumor Microenvironment in T-Cell Lymphomas.

  2018cites this paper
• The Role of Macrophage/B-Cell Interactions in the Pathophysiology of B-Cell Lymphomas

  2018cites this paper
• Monomorphic Post-transplant Lymphoproliferative Disorder After Kidney Transplantation and Hematopoietic Stem Cell Transplantation: Clinicopathological Characteristics, Treatments and Prognostic Factors

  2017cites this paper
• Follicular lymphomas and their transformation: Past and current research

  2017cites this paper
• Management of B-Cell Lymphoma: Where Are We Now and Where Are We Going?

  2017cites this paper
• Obinutuzumab: what is there to learn from clinical trials?

  2017cites this paper
• Unmet needs in histological transformation of follicular lymphoma: a clinical and biological review

  2017cites this paper
• Regulatory myeloid cells: an underexplored continent in B-cell lymphomas

  2017cites this paper
• Rituximab treatment circumvents the prognostic impact of tumor-infiltrating T-cells in follicular lymphoma patients.

  2017cites this paper
• Hurdles and Unmet Needs in the Management of Indolent Non-Hodgkin Lymphoma

  2017cites this paper
• Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium

  2017cites this paper
• Follicular lymphoma: are we ready for a risk-adapted approach?

  2017cites this paper
• Extrafollicular PD1 and Intrafollicular CD3 Expression Are Associated With Survival in Follicular Lymphoma

  2017cites this paper
• Follicular Lymphoma: The Role of the Tumor Microenvironment in Prognosis.

  2016cites this paper
• Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma

  2016cites this paper
• Analysis of dendritic cell subpopulations in follicular lymphoma with respect to the tumor immune microenvironment

  2016cites this paper
• The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era

  2016influential citation
• PD-1 Blunts the Function of Ovarian Tumor-Infiltrating Dendritic Cells by Inactivating NF-κB.

  2016cites this paper
• Tumor‐Associated Macrophages Associate with Cerebrospinal Fluid Interleukin‐10 and Survival in Primary Central Nervous System Lymphoma (PCNSL)

  2016cites this paper
• Follicular lymphoma: evolving therapeutic strategies.

  2016cites this paper
• Role of tumor‐associated macrophages in human malignancies: friend or foe?

  2016cites this paper
• Prognostic value of lymphocyte/monocyte ratio in advanced Hodgkin lymphoma: correlation with International Prognostic Score and tumor associated macrophages

  2016cites this paper
• Mecanismos de progresión y transformación en linfomas de células B de bajo grado: Alteraciones citogenéticas y moleculares

  2016cites this paper
• Effects of autophagy regulation of tumor-associated macrophages on radiosensitivity of colorectal cancer cells.

  2016cites this paper
• Host- and Tumour-related Prognostic Factors in Diffuse Large B-cell Lymphoma

  2016cites this paper
• Optimising B-cell depletion in autoimmune disease: is obinutuzumab the answer?

  2016cites this paper
• Prognostic factors in follicular lymphoma: new tools to personalize risk.

  2016cites this paper
• Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises.

  2016cites this paper
• CME Information: Follicular lymphoma: 2015 update on diagnosis and management

  2015cites this paper